Plain-English translation of NCT07048795 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating the mylife CamAPS FX system, which is a hybrid closed-loop insulin pump that works automatically with a Dexcom G6 glucose sensor to manage blood sugar levels. Researchers want to see how well this treatment works in everyday life for people with type 1 diabetes in France, and how it affects both blood sugar control and quality of life. The system has already been approved for use, but this study is gathering real-world information to confirm it's working as intended.
French health authorities asked for this follow-up study to understand how this treatment performs in real patients outside of controlled clinical settings. The goal is to ensure the system continues to work safely and effectively for people managing type 1 diabetes every day.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will start using the mylife CamAPS FX system combined with the Dexcom G6 sensor, which you'll wear and use according to your doctor's instructions. Throughout the study, you'll complete online questionnaires about your blood sugar levels and how the system affects your daily life and well-being. The study follows you over time as you use this system in your normal routine, allowing researchers to gather real-world information about how it works for you.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France